Jun 26, 2026 09:35AM
Apr 30, 2026 06:25AM
Dec 29, 2025 04:47AM
Sep 24, 2025 09:27AM
Jun 26, 2025 10:05AM
Jan 23, 2025 10:26AM
Sep 3, 2024 09:33AM Teva Pharma (TEVA) PT Raised to $26 at UBS
Jul 10, 2024 08:24AM
Nov 27, 2023 01:12PM
Nov 27, 2023 11:21AM
Nov 27, 2023 03:40AM
Jul 6, 2023 04:10PM
Jul 6, 2023 04:51AM
Oct 21, 2022 05:50PM Today's Most Important Initiations
Jun 13, 2022 04:52PM
May 4, 2021 04:21AM
Apr 6, 2020 04:48AM
Aug 16, 2019 07:03AM
Jul 15, 2019 09:28AM
May 28, 2019 02:56AM
Mar 7, 2019 05:53AM UBS Resumes Teva Pharma (TEVA) at Buy
Feb 11, 2019 09:29AM
Jan 23, 2019 09:10AM
Dec 18, 2017 08:14AM
Oct 4, 2017 07:54AM
Aug 7, 2017 09:33AM
May 4, 2016 10:49AM
Oct 1, 2015 09:21AM Pre-Open Stock Movers 10/01: (XOMA) (SRPT) (PBF) Higher; (MDGN) (CXO) (AGCO) Lower (more...)
Jul 27, 2015 09:58AM
Jul 15, 2015 09:02AM
Mar 18, 2015 09:25AM
Dec 12, 2014 10:59AM
Apr 30, 2014 10:25AM
Dec 6, 2013 12:12PM
Nov 4, 2013 10:44AM Notable Analyst Rating Changes 11/04: (X) (GTI) (KSS) Upgraded; (BPI) (GPS) (AFL) Downgraded
Aug 5, 2013 10:52AM
Jul 30, 2013 10:58AM
Dec 3, 2012 06:41AM
Jun 26, 2012 11:05AM
Jun 25, 2012 12:46PM
May 25, 2012 10:52AM
Mar 15, 2012 10:43AM Notable Analyst Rating Changes 03/15: (AMD) (UNP) (LVLT) Upgraded; (EBAY) (LAZ) (WMS) Downgraded
Jan 12, 2012 01:55PM
Nov 8, 2011 11:05AM
Nov 3, 2011 11:15AM
Nov 3, 2011 11:12AM
Oct 24, 2011 10:47AM
Aug 1, 2011 03:08PM
Jul 18, 2011 11:42AM UBS Maintains a 'Neutral' on Amgen (AMGN); Revising Estimates on Biosimilars Deal
May 9, 2011 11:02AM

169,931 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All